Mold infections of the central nervous system

New England Journal of Medicine

Volumn 371, Issue 2, 2014, Pages 150-160

  McCarthy, Matthew ^a   Rosengart, Axel ^a   Schuetz, Audrey N ^a   Kontoyiannis, Dimitrios P ^b   Walsh, Thomas J ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; GALACTOMANNAN; VORICONAZOLE;

ANTIGEN DETECTION; BRAIN BIOPSY; CENTRAL NERVOUS SYSTEM ASPERGILLOSIS; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; EARLY DIAGNOSIS; EPIDEMIC; FUSARIOSIS; HUMAN; IMMUNOREGULATION; INNATE IMMUNITY; MANAGED CARE; MUCORMYCOSIS; MYCOSIS; NEUROSURGERY; NONHUMAN; PRIORITY JOURNAL; PSEUDALLESCHERIASIS; REVIEW; TREATMENT OUTCOME;

ANTIFUNGAL AGENTS; CENTRAL NERVOUS SYSTEM FUNGAL INFECTIONS; EARLY DIAGNOSIS; FUNGI; HUMANS;

EID: 84903890121     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMra1216008     Document Type: Review

References (53)

1. Smith RM, Schaefer MK, Kainer MA, et al. Fungal infections associated with contaminated methylprednisolone injections. N Engl J Med 2013;369:1598-609.
2. Segal BH. Aspergillosis. N Engl J Med 2009;360:1870-84.
3. Perfect JR. Iatrogenic fungal meningitis: tragedy repeated. Ann Intern Med 2012;157:825-6.
4. Walsh TJ, Hier DB, Caplan LR. Fungal infections of the central nervous system: comparative analysis of risk factors and clinical signs in 57 patients. Neurology 1985;35:1654-7. (Pubitemid 16248681)
5. Li DM, de Hoog GS. Cerebral phaeohyphomycosis - a cure at what lengths? Lancet Infect Dis 2009;9:376-83.
6. Soeffker G, Wichmann D, Loderstaedt U, Sobottka I, Deuse T, Kluge S. Aspergillus galactomannan antigen for diagnosis and treatment monitoring in cerebral aspergillosis. Prog Transplant 2013;23:71-4.
7. Mikulska M, Furfaro E, Del Bono V, et al. (1-3)-β-D-glucan in cerebrospinal fluid is useful for the diagnosis of central nervous system fungal infections. Clin Infect Dis 2013;56:1511-12.
8. Tortorano AM, Esposto MC, Prigitano A, et al. Cross-reactivity of Fusarium spp. in the Aspergillus galactomannan enzyme-linked immunosorbent assay. J Clin Microbiol 2012;50:1051-3.
9. Reinwald M, Buchheidt D, Hummel M, et al. Diagnostic performance of an Aspergillus-specific nested PCR assay in cerebrospinal fluid samples of immunocompromised patients for detection of central nervous system aspergillosis. PLoS One 2013;8(2):e56706.
10. Johnson EM, Szekely A, Warnock DW. In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi. J Antimicrob Chemother 1998;42:741-5. (Pubitemid 29008075)
11. Pfaller MA, Espinel-Ingroff A, Canton E, et al. Wild-type MIC distributions and epidemiological cutoff values for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI broth microdilution. J Clin Microbiol 2012;50:2040-6.
12. Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008;46:327-60. (Pubitemid 351265310)
13. Schwartz S, Thiel E. Cerebral aspergillosis: tissue penetration is the key. Med Mycol 2009;47:Suppl 1:S387-S393.
14. Rambach G, Hagleitner M, Mohsenipour I, et al. Antifungal activity of the local complement system in cerebral aspergillosis. Microbes Infect 2005;7:1285-95. (Pubitemid 41572306)
15. Ben-Ami R, Lewis RE, Raad II, Kontoyiannis DP. Phaeohyphomycosis in a tertiary care cancer center. Clin Infect Dis 2009;48:1033-41.
16. Katragkou A, Roilides E. Immunotherapy of infections caused by rare filamentous fungi. Clin Microbiol Infect 2012;18:134-9.
17. Antinori S, Corbellino M, Meroni L, et al. Aspergillus meningitis: a rare clinical manifestation of central nervous system aspergillosis: case report and review of 92 cases. J Infect 2013;66:218-38.
18. Pettit AC, Kropski JA, Castilho JL, et al. The index case for the fungal meningitis outbreak in the United States. N Engl J Med 2012;367:2119-25.
19. Kourkoumpetis TK, Desalermos A, Muhammed M, Mylonakis E. Central nervous system aspergillosis: a series of 14 cases from a general hospital and review of 123 cases from the literature. Medicine (Baltimore) 2012;91:328-36.
20. Iihara K, Makita Y, Nabeshima S, Tei T, Keyaki A, Nioka H. Aspergillosis of the central nervous system causing subarachnoid hemorrhage from mycotic aneurysm of the basilar artery - case report. Neurol Med Chir (Tokyo) 1990;30:618-23.
21. Herbrecht R, Letscher-Bru V, Oprea C, et al. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J Clin Oncol 2002;20:1898-906. (Pubitemid 34273282)
22. Hammond SP, Baden LR, Marty FM. Mortality in hematologic malignancy and hematopoietic stem cell transplant patients with mucormycosis, 2001 to 2009. Antimicrob Agents Chemother 2011;55:5018-21.
23. Mantadakis E, Samonis G. Clinical presentation of zygomycosis. Clin Microbiol Infect 2009;15:Suppl 5:15-20.
24. McNulty JS. Rhinocerebral mucormycosis: predisposing factors. Laryngoscope 1982;92:1140-3. (Pubitemid 12003259)
25. Hopkins RJ, Rothman M, Fiore A, Goldblum SE. Cerebral mucormycosis associated with intravenous drug use: three case reports and review. Clin Infect Dis 1994;19:1133-7. (Pubitemid 24380030)
26. Ibrahim AS, Spellberg B, Walsh TJ, Kontoyiannis DP. Pathogenesis of mucormycosis. Clin Infect Dis 2012;54:Suppl 1:S16-S22.
27. Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis 2012;54: Suppl 1:S23-S34.
28. McDermott NE, Barrett J, Hipp J, et al. Successful treatment of periodontal mucormycosis: report of a case and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010;109(3):e64-e69.
29. Greenberg RN, Mullane K, van Burik JA, et al. Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother 2006;50:126-33. (Pubitemid 43042912)
30. Spellberg B, Ibrahim AS, Chin-Hong PV, et al. The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial. J Antimicrob Chemother 2012;67:715-22.
31. Spellberg B, Ibrahim A, Roilides E, et al. Combination therapy for mucormycosis: why, what, and how? Clin Infect Dis 2012;54:Suppl 1:S73-S78.
32. Martino P, Gastaldi R, Raccah R, Girmenia C. Clinical patterns of Fusarium infections in immunocompromised patients. J Infect 1994;28:Suppl 1:7-15.
33. Steinberg GK, Britt RH, Enzmann DR, Finlay JL, Arvin AM. Fusarium brain abscess: case report. J Neurosurg 1983;58:598-601. (Pubitemid 13121099)
34. Lamaris GA, Esmaeli B, Chamilos G, et al. Fungal endophthalmitis in a tertiary care cancer center: a review of 23 cases. Eur J Clin Microbiol Infect Dis 2008;27:343-7.
35. Anaissie E, Paetznick V, Proffitt R, Adler-Moore J, Bodey GP. Comparison of the in vitro antifungal activity of free and liposome-encapsulated amphotericin B. Eur J Clin Microbiol Infect Dis 1991;10:665-8.
36. Dignani MC, Anaissie E. Human fusariosis. Clin Microbiol Infect 2004;10: Suppl 1:67-75. (Pubitemid 38379952)
37. Cortez KJ, Roilides E, Quiroz-Telles F, et al. Infections caused by Scedosporium spp. Clin Microbiol Rev 2008;21:157-97.
38. Montejo M, Muñiz ML, Zárraga S, et al. Case reports: infection due to Scedosporium apiospermum in renal transplant recipients: a report of two cases and literature review of central nervous system and cutaneous infections by Pseudallescheria boydii/Sc. apiospermum. Mycoses 2002;45:418-27. (Pubitemid 35357018)
39. Troke P, Aguirrebengoa K, Arteaga C, et al. Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients. Antimicrob Agents Chemother 2008;52:1743-50. (Pubitemid 351614668)
40. Revankar SG, Sutton DA, Rinaldi MG. Primary central nervous system phaeohyphomycosis: a review of 101 cases. Clin Infect Dis 2004;38:206-16. (Pubitemid 38113028)
41. Al-Tawfiq JA, Boukhamseen A. Cerebral phaeohyphomycosis due to Rhinocladiella mackenziei (formerly Ramichloridium mackenziei): case presentation and literature review. J Infect Public Health 2011;4:96-102.
42. Kauffman CA, Pappas PG, Patterson TF. Fungal infections associated with contaminated methylprednisolone injections. N Engl J Med 2013;368:2495-500.
43. Kainer MA, Reagan DR, Nguyen DB, et al. Fungal infections associated with contaminated methylprednisolone in Tennessee. N Engl J Med 2012;367:2194-203.
44. Dixon DM, Walsh TJ, Merz WG, McGinnis MR. Infections due to Xylohypha bantiana (Cladosporium trichoides). Rev Infect Dis 1989;11:515-25.
45. Lyons MK, Blair JE, Leslie KO. Successful treatment with voriconazole of fungal cerebral abscess due to Cladophialophora bantiana. Clin Neurol Neurosurg 2005;107:532-4. (Pubitemid 41395233)
46. Qureshi ZA, Kwak EJ, Nguyen MH, Silveira FP. Ochroconis gallopava: a dematiaceous mold causing infections in transplant recipients. Clin Transplant 2012;26:E17-E23.
47. Shoham S, Pic-Aluas L, Taylor J, Cortez K, et al. Transplant-associated Ochroconis gallopava infections. Transpl Infect Dis 2008;10:442-8.
48. Stevens DA. Reflections on the approach to treatment of a mycologic disaster. Antimicrob Agents Chemother 2013;57:1567-72.
49. Gade L, Scheel CM, Pham CD, et al. Detection of fungal DNA in human body fluids and tissues during a multistate outbreak of fungal meningitis and other infections. Eukaryot Cell 2013;12:677-83.
50. Zhao Y, Petraitiene R, Walsh TJ, Perlin DS. A real-time PCR assay for rapid detection and quantification of Exserohilum rostratum, a causative pathogen of fungal meningitis associated with injection of contaminated methylprednisolone. J Clin Microbiol 2013;51:1034-6.
51. Lyons JL, Roos KL, Marr KA, et al. Cerebrospinal fluid (1,3)-β-D-glucan detection as an aid for diagnosis of iatrogenic fungal meningitis. J Clin Microbiol 2013;51:1285-7.
52. Litvintseva AP, Lindsley MD, Gade L, et al. Utility of (1-3)-β-D-glucan testing for diagnostics and monitoring response to treatment during the multistate outbreak of fungal meningitis and other infections. Clin Infect Dis 2014;58:622-30.
53. Kontoyiannis DP, Perlin DS, Roilides E, Walsh TJ. What can we learn and what do we need to know amidst the iatrogenic outbreak of Exserohilum rostratum meningitis? Clin Infect Dis 2013;57:853-9.